1. Home
  2. CYCC vs IVP Comparison

CYCC vs IVP Comparison

Compare CYCC & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • IVP
  • Stock Information
  • Founded
  • CYCC 1992
  • IVP 2020
  • Country
  • CYCC United States
  • IVP United States
  • Employees
  • CYCC N/A
  • IVP N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • IVP Diversified Commercial Services
  • Sector
  • CYCC Health Care
  • IVP Miscellaneous
  • Exchange
  • CYCC Nasdaq
  • IVP Nasdaq
  • Market Cap
  • CYCC 3.6M
  • IVP 3.0M
  • IPO Year
  • CYCC N/A
  • IVP 2023
  • Fundamental
  • Price
  • CYCC $0.25
  • IVP $1.74
  • Analyst Decision
  • CYCC Strong Buy
  • IVP
  • Analyst Count
  • CYCC 1
  • IVP 0
  • Target Price
  • CYCC $11.00
  • IVP N/A
  • AVG Volume (30 Days)
  • CYCC 160.2K
  • IVP 92.7K
  • Earning Date
  • CYCC 05-13-2025
  • IVP 05-14-2025
  • Dividend Yield
  • CYCC N/A
  • IVP N/A
  • EPS Growth
  • CYCC N/A
  • IVP N/A
  • EPS
  • CYCC N/A
  • IVP N/A
  • Revenue
  • CYCC $74,000.00
  • IVP $16,592,109.00
  • Revenue This Year
  • CYCC N/A
  • IVP N/A
  • Revenue Next Year
  • CYCC $88.68
  • IVP N/A
  • P/E Ratio
  • CYCC N/A
  • IVP N/A
  • Revenue Growth
  • CYCC N/A
  • IVP 6.12
  • 52 Week Low
  • CYCC $0.22
  • IVP $1.60
  • 52 Week High
  • CYCC $4.00
  • IVP $401.50
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 29.30
  • IVP 36.63
  • Support Level
  • CYCC $0.29
  • IVP $1.60
  • Resistance Level
  • CYCC $0.32
  • IVP $1.76
  • Average True Range (ATR)
  • CYCC 0.02
  • IVP 0.12
  • MACD
  • CYCC -0.00
  • IVP 0.02
  • Stochastic Oscillator
  • CYCC 19.92
  • IVP 25.00

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Share on Social Networks: